AMALGAMATED BANK - DENALI THERAPEUTICS INC ownership

DENALI THERAPEUTICS INC's ticker is DNLI and the CUSIP is 24823R105. A total of 202 filers reported holding DENALI THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 9.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
AMALGAMATED BANK ownership history of DENALI THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$97
+16.9%
4,192
+4.2%
0.00%0.0%
Q1 2024$83
-77.3%
4,024
-76.4%
0.00%
-66.7%
Q4 2023$366
-2.9%
17,057
-6.6%
0.00%0.0%
Q3 2023$377
-27.4%
18,255
+3.9%
0.00%
-25.0%
Q2 2023$519
+46.6%
17,576
+14.3%
0.00%
+33.3%
Q1 2023$354
-29.1%
15,380
-14.4%
0.00%
-25.0%
Q4 2022$499
-99.9%
17,959
+12.7%
0.00%
-20.0%
Q3 2022$489,000
+6.8%
15,942
+2.4%
0.01%
+25.0%
Q2 2022$458,000
-4.4%
15,562
+4.5%
0.00%0.0%
Q1 2022$479,000
-66.5%
14,893
-53.5%
0.00%
-20.0%
Q4 2021$1,428,000
+75.0%
32,024
+97.9%
0.01%
-28.6%
Q3 2021$816,000
-39.5%
16,184
-5.8%
0.01%
-36.4%
Q2 2021$1,348,000
+163.8%
17,181
+91.9%
0.01%
-42.1%
Q1 2021$511,000
-37.9%
8,953
-8.9%
0.02%
-38.7%
Q4 2020$823,000
+135.1%
9,828
+0.5%
0.03%
+106.7%
Q3 2020$350,000
+44.0%
9,779
-2.8%
0.02%
+36.4%
Q2 2020$243,00010,0640.01%
Other shareholders
DENALI THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Crestline Management, LP 19,462,500$404,042,00054.41%
Bratton Capital Management, L.P. 953,035$19,785,00029.05%
Flagship Pioneering Inc. 8,005,747$166,199,0007.19%
Casdin Capital, LLC 400,000$8,304,000,0000.78%
Temasek Holdings (Private) Ltd 4,410,457$91,561,0000.65%
IRONWOOD INVESTMENT MANAGEMENT LLC 22,595$469,0000.37%
MARK ASSET MANAGEMENT LP 70,532$1,464,0000.34%
Artal Group S.A. 400,000$8,304,0000.34%
PIER 88 INVESTMENT PARTNERS LLC 27,650$574,0000.24%
WASATCH ADVISORS LP 996,147$20,680,0000.20%
View complete list of DENALI THERAPEUTICS INC shareholders